C-suite barometer: life sciences & pharmaceuticals sector view

In a year marked by global uncertainty, shifting regulations, and fast-moving innovation, leaders in the life sciences & pharmaceuticals sector are redefining their strategic priorities. Drawing on insights from executives from across more than 35 countries, our latest report captures how sector players are navigating complexity, investing in growth, and positioning themselves for long-term success in a competitive landscape.

Download the full report:

Featuring commentary from our Forvis Mazars experts and contributors including Damien Catoir, Servier, and Cédric Moreau, Sofinnova Partners, the report provides a valuable benchmark for sector players looking to navigate a rapidly evolving landscape.

“What is striking about this year's findings is the high levels of optimism in the life sciences & pharmaceutical sector, with 98% of C-suite leaders indicating a positive growth outlook for their businesses in 2025. What is behind such optimism are robust drug pipelines and significant investments in R&D, allowing the sector to grow revenues that put it in a strong position to support future growth ambitions.”
Nigel Layton
Partner, Head of Life Sciences, Forvis Mazars Group

Key findings 

• 96% report growth, with a clear majority also boasting growing revenues, eleven points higher than others globally.
• 55% of C-suite executives cite increased competition and 47% cite supply chain restrictions as the top factors holding back growth.
• 39% of leaders identify economic factors as having the biggest impact on businesses, with 37% viewing the emergence of technologies as significant.
• 67% of firms in the sector are boosting investment, averaged across all business activities

Looking ahead, executives have outlined three core strategic priorities for 2025 and beyond: entering new products and services, accelerating digital transformation to enhance efficiency and agility, international expansion, and strengthening supply chains in response to geopolitical and climate risks- particularly sustainability and supplier responsibility- into core business strategy.

Explore the full findings and discover how sector leaders are preparing for growth in a complex and competitive environment.